patient characteristics

The Presentation, Recognition and Management of Bipolar Depression in Primary Care.

The Presentation, Recognition and Management of Bipolar Depression in Primary Care.

J Gen Intern Med. 2013 Jul 9;
Cerimele JM, Chwastiak LA, Chan YF, Harrison DA, Unützer J

Bipolar disorder is a mood disorder characterized by episodes of major… Continue reading →

Fire Eater’s Lung: Retrospective Analysis of 123 Cases Reported to a National Poison Center.

Fire Eater’s Lung: Retrospective Analysis of 123 Cases Reported to a National Poison Center.

Respiration. 2013 Jun 21;
Franzen D, Kohler M, Degrandi C, Kullak-Ublick GA, Ceschi A

Background: Fire eater’s lung (FEL) is a distinct form of acute… Continue reading →

PROFILEing Idiopathic Pulmonary Fibrosis: Rethinking Biomarker Discovery.

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.

Eur Respir Rev. 2013 Jun 1; 22(128): 148-152
Maher TM

Despite major advances in the understanding of the pathogenesis of idiopathic pulmonary fibrosis (IPF), diagnosis and management of the condition continue to… Continue reading →

Beyond Anti-VEGF: Dual-Targeting Antiangiogenic and Antiproliferative Therapy.

Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy.

Am J Transl Res. 2013; 5(4): 393-403
Chen CT, Hung MC

Antiangiogenesis is a promising antitumor strategy that inhibits tumor vascular formation to suppress tumor growth. Specifically, targeting VEGF has shown therapeutic… Continue reading →

Efficacy of Add-on Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder: Three Case Reports.

Efficacy of Add-On Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder: Three Case Reports.

Prim Care Companion CNS Disord. 2013; 15(1):
Rapinesi C, Kotzalidis GD, Serata D, Casale AD, Bersani FS, Solfanelli A, Scatena P, Raccah… Continue reading →

The Care Delivery Experience of Hospitalized Patients With Complex Chronic Disease.

The care delivery experience of hospitalized patients with complex chronic disease.

Health Expect. 2013 May 27;
Kuluski K, Hoang SN, Schaink AK, Alvaro C, Lyons RF, Tobias R, Bensimon CM

OBJECTIVE: This study investigated what is important in care… Continue reading →

Induction Chemotherapy in Technically Unresectable Locally Advanced Oral Cavity Cancers: Does It Make a Difference?

Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: Does it make a difference?

Indian J Cancer. 2013 Jan-Mar; 50(1): 1-8
Patil VM, Noronha V, Muddu VK, Gulia S, Bhosale B, Arya S, Juvekar S, Chatturvedi P, Chaukar… Continue reading →

The Neuropsychiatry of Inborn Errors of Metabolism.

The neuropsychiatry of inborn errors of metabolism.

J Inherit Metab Dis. 2013 May 23;
Walterfang M, Bonnot O, Mocellin R, Velakoulis D

A number of metabolic disorders that affect the central nervous system can present in childhood, adolescence or… Continue reading →

Cognitive Function in Older Women With Breast Cancer Treated With Standard Chemotherapy and Capecitabine on Cancer and Leukemia Group B 49907.

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.

Breast Cancer Res Treat. 2013 May 17;
Freedman RA, Pitcher B, Keating NL, Ballman KV, Mandelblatt J, Kornblith… Continue reading →

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity Versus Functional Activities.

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.

Medchemcomm. 2013 May 1; 4(5): 847-851
Yuan Y, Arnatt CK, El-Hage N, Dever SM, Jacob JC, Selley DE, Hauser KF,… Continue reading →